|
Biocon share price touched a new 52 weeks and lifetime high recently, on 28th June 2016. The 52-week low value for Biocon share price is Rs. 395.30 on 24-Aug-15 and the lifetime low value is Rs. 85.00 on 02-Dec-08. The Average Daily Movement of the stock is 16.25 and the Average Value for 20 days is 682839. For more information on Biocon Share price, visit the Biocon Share price history page of Dynamic Levels website. The story of how Biocon India was incorporated is no secret. Kiran Mazumdar-Shaw started Biocon India with a long and exciting story. Biocon is just not about just success, but it is about beginning from the beginning and taking it to the heights. It is about how its founder dropped her certain life to take up this uncertain challenge. And it is about how her relentless efforts paid in full. Biocon share price, as a result, made a new lifetime high on 28th June 2016. About Biocon: The day Biocon incorporated was the day of the start of a biorevolution in India. The evolution of Biocon has been impressive- from an enzyme-manufacturing company into a fully integrated biopharmaceutical enterprise. Today, the company hold a dangerous combination of proprietary fermentation technologies and research skills to develop affordable therapy for unmet medical needs. Biocon India was born as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. Subsidiary companies: Syngene International Limited: A custom research organization that offers synthetic chemistry and molecular biology services for early stage drug discovery and development. Biocon Pharma Limited (BPL): A joint venture with CIMAB to develop and market a range of monoclonal antibodies and cancer vaccines. Biocon acquired CIMAB’s 49% stake in March 2010, and BBPL became a 100% subsidiary. Biocon Research Limited (BRL): A wholly owned subsidiary that was set up to undertake the discovery and development research work in biologics, antibody molecules, and proteins. NeoBiocon FZ LLC: A research and marketing pharmaceutical company based in Abu Dhabi. It was Incorporated in January 2008. NeoBiocon is a 50:50 joint venture with Dr. B.R.Shetty, Managing Director of NeoPharma, Abu Dhabi. Biocon SA: A wholly owned subsidiary in Switzerland engaged mainly in the development and commercialization of biopharmaceuticals across the globe. Biocon SDN. BHD: A wholly owned subsidiary in Malaysia to set up an original manufacturing facility at BioXcell a biotechnology park promoted by the Government of Malaysia. Financial Analysis: Revenue: Biocon's revenue for Q12016 has been in highest among the last five quarters. Q12016 recorded the revenue of 641.00 crores, as against the revenues of the four quarters of past fiscal year which stood at 583.38 crores for Q12015, 583.38 crores for Q22015, 558.48 crores for Q32015 and 533.00 crores for Q42015. Net Profit: The Net profit of Biocon for Q1 in FY 2016 has been nothing in compared to what it recorded in Q3 of FY 2015. The Net profit of Biocon for last five subsequent quarters are 138.20 crores for Q12016, 68.50 crores for Q42015, 498.64 crores for Q32015, for Q22015 it has been 103.43 crores and for Q12015 the net profit was 47.79 crores. Market watch: Biocon is among the top 500 performing stocks according to Dynamic levels. The stock has not made any losses in last two quarters, its debt-equity is less than 2 and pledge less that 25%. Biocon share price touched a new 52 weeks and lifetime high recently, on 28th June 2016. The 52-week low value for Biocon share price is Rs. 395.30 on 24-Aug-15 and the lifetime low value is Rs. 85.00 on 02-Dec-08. The Average Daily Movement of the stock is 16.25 and the Average Value for 20 days is 682839. For more information on Biocon Share price, visit the Biocon Share price history page of Dynamic Levels website.
Related Articles -
Biocon, share, Price,
| 
